524091 — Carysil Balance Sheet
0.000.00%
- IN₹25.89bn
- IN₹27.93bn
- IN₹8.16bn
- 67
- 12
- 98
- 65
Annual balance sheet for Carysil, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 222 | 131 | 122 | 130 | 676 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,371 | 1,844 | 1,995 | 2,150 | 2,240 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,209 | 3,076 | 3,530 | 4,143 | 5,264 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,361 | 2,013 | 2,366 | 2,617 | 2,743 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,912 | 5,533 | 7,123 | 8,447 | 9,853 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,662 | 2,426 | 3,104 | 3,548 | 3,497 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,998 | 2,996 | 4,089 | 4,907 | 4,588 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1,914 | 2,537 | 3,034 | 3,540 | 5,265 |
| Total Liabilities & Shareholders' Equity | 3,912 | 5,533 | 7,123 | 8,447 | 9,853 |
| Total Common Shares Outstanding |